← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	GRML 76 Greenland Mines Ltd GRML $92.9M	24	-1	-4%	$56.5M
77	77 IN8bio INAB $11.7M	21	-1	-5%	$2.58M
78	78 Lunai Bioworks LNAI $4.05M	21	-9	-30%	$6.65M
79	79 Candel Therapeutics CADL $682M	20	0	0%	$4.86M
80	80 DELISTED Orgenesis Inc. Common Stock ORGS	20	-2	-9%	$980K
81	ACHL 81 DELISTED Achilles Therapeutics ACHL	18	0	0%	$17.9M
82	LGVN 82 Longeveron LGVN $4.78M	18	-1	-5%	$1.37M
83	83 DELISTED Scorpius Holdings, Inc. SCPX	18	+1	+6%	$1.15M
84	84 Genprex GNPX $1.88M	17	0	0%	$2.61M
85	85 BioCardia BCDA $14.2M	16	-7	-30%	$710K
86	86 Immix Biopharma IMMX $720M	16	-2	-11%	$1.39M
87	87 Coya Therapeutics COYA $102M	15	+1	+7%	$5.45M
88	88 Enlivex Ltd ENLV $4.46M	15	-4	-21%	$408K
89	89 Imunon IMNN $5.95M	15	-1	-6%	$403K
90	90 DELISTED NKGen Biotech, Inc. Common Stock NKGN	13	-12	-48%	$47.9M
91	91 Benitec Biopharma BNTC $295M	12	-5	-29%	$3.84M
92	FRLN 92 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	12	+1	+9%	$9.87M
93	93 BioRestorative Therapies BRTX $2.02M	11	-1	-8%	$649K
94	TCBP 94 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	11	+5	+83%	$646K
95	95 DELISTED CERo Therapeutics CERO	10	-2	-17%	$7.33M
96	96 Calidi Biotherapeutics CLDI $2.25M	10	-14	-58%	$3.54M
97	97 Eterna Therapeutics ERNA $2.53M	9	-1	-10%	$728K
98	98 Creative Medical Technology CELZ $6.21M	8	-1	-11%	$104K
99	99 NewcelX Ltd NCEL $16.5M	6	-1	-14%	$4.35M
100	SQZ 100 DELISTED SQZ Biotechnologies Company SQZ	5	-26	-84%	$333K